Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ATYRthis companyaTyr Pharma, Inc.	$6.51	-0.98×	1.08×	383.2×	-1.02×	-128.4%	-717.4%	-40856.3%	-39009.5%	-109.8%	-96.5%	-85.2%	0.18×	-0.02×	0×	5.3×	0.0%	2	-14.23	2	C
ACRVAcrivon Therapeutics, Inc. Common Stock	$1.67	-1.19×	0.82×	0×	-0.71×	-40.7%	0.0%	0.0%	0.0%	-69.2%	-73.0%	-70.4%	0.02×	0.51×	0×	7.69×	0.0%	1	-2.78	3	B-
ALXOALX Oncology Holdings Inc.	$1.23	-0.59×	2.33×	0×	-0.5×	-90.6%	0.0%	0.0%	0.0%	-391.4%	-262.0%	-139.1%	0.2×	0.11×	-64.93×	2.07×	0.0%	2	-2.66	2	C
CAMPCAMP4 Therapeutics Corporation	$4.36	-2.31×	3.9×	53.24×	-1.56×	-1164.1%	53.1%	-1488.3%	-2298.5%	-168.5%	-50.8%	-16.0%	0.04×	2.13×	0×	7.35×	0.0%	1	-5.32	2	C
DTILPrecision BioSciences, Inc.	$10.38	-1.17×	0.58×	1.56×	0.68×	-257.3%	100.0%	-152.2%	-133.4%	-49.6%	-35.5%	-123.6%	0.31×	1.93×	-36.67×	13.32×	0.0%	3	-4.84	1	C-
HYFTMindWalk Holdings Corp.	$1.09	-5.39×	6.39×	4.89×	-5.11×	-295.2%	58.8%	-96.0%	-89.7%	-117.1%	-89.2%	-16.9%	0.3×	0.59×	0×	2.8×	0.0%	3	-9.88	1	D+
Peer median	—	-1.19×	2.33×	1.56×	-0.71×	-257.3%	53.1%	-96.0%	-89.7%	-117.1%	-73.0%	-70.4%	0.2×	0.59×	0×	7.35×	0.0%	2	-4.84	2	—